

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 5.48845520 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 4.65631919 |
| 3 | regulation of cholesterol storage (GO:0010885) | 4.60481316 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24815715 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24815715 |
| 6 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.82043072 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 3.79699483 |
| 8 | valine metabolic process (GO:0006573) | 3.72397596 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67436826 |
| 10 | carnitine shuttle (GO:0006853) | 3.64258596 |
| 11 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.62515706 |
| 12 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56495938 |
| 13 | apoptotic cell clearance (GO:0043277) | 3.55430676 |
| 14 | positive regulation of histone deacetylation (GO:0031065) | 3.54085237 |
| 15 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.53460300 |
| 16 | regulation of fatty acid oxidation (GO:0046320) | 3.53368701 |
| 17 | carnitine transmembrane transport (GO:1902603) | 3.52829061 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.46749861 |
| 19 | protein carboxylation (GO:0018214) | 3.46749861 |
| 20 | carnitine transport (GO:0015879) | 3.42214832 |
| 21 | amino-acid betaine transport (GO:0015838) | 3.42214832 |
| 22 | positive regulation of fatty acid oxidation (GO:0046321) | 3.36754185 |
| 23 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.36610953 |
| 24 | triglyceride catabolic process (GO:0019433) | 3.30411537 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22765987 |
| 26 | positive regulation of lipid storage (GO:0010884) | 3.22412604 |
| 27 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.17388738 |
| 28 | pentose-phosphate shunt (GO:0006098) | 3.17215417 |
| 29 | positive regulation of extracellular matrix organization (GO:1903055) | 3.15910823 |
| 30 | regulation of extracellular matrix disassembly (GO:0010715) | 3.15599489 |
| 31 | white fat cell differentiation (GO:0050872) | 3.15318245 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.13250875 |
| 33 | growth hormone receptor signaling pathway (GO:0060396) | 3.11471907 |
| 34 | acylglycerol catabolic process (GO:0046464) | 3.05986601 |
| 35 | neutral lipid catabolic process (GO:0046461) | 3.05986601 |
| 36 | sexual reproduction (GO:0019953) | 3.03845987 |
| 37 | COPII vesicle coating (GO:0048208) | 3.03505024 |
| 38 | negative regulation of lipid storage (GO:0010888) | 3.02711312 |
| 39 | cellular response to arsenic-containing substance (GO:0071243) | 3.00568615 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.00145031 |
| 41 | protein localization to endosome (GO:0036010) | 2.95927584 |
| 42 | Golgi transport vesicle coating (GO:0048200) | 2.94779378 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 2.94779378 |
| 44 | positive regulation of lipid catabolic process (GO:0050996) | 2.94674977 |
| 45 | negative regulation of cell size (GO:0045792) | 2.92779999 |
| 46 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.91098424 |
| 47 | fatty acid beta-oxidation (GO:0006635) | 2.90981671 |
| 48 | macroautophagy (GO:0016236) | 2.90923244 |
| 49 | NADPH regeneration (GO:0006740) | 2.90155340 |
| 50 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.89038446 |
| 51 | intracellular lipid transport (GO:0032365) | 2.86733959 |
| 52 | brown fat cell differentiation (GO:0050873) | 2.85840832 |
| 53 | negative regulation of type 2 immune response (GO:0002829) | 2.85121049 |
| 54 | negative regulation of fatty acid transport (GO:2000192) | 2.81188349 |
| 55 | tricarboxylic acid metabolic process (GO:0072350) | 2.79251508 |
| 56 | cellular response to growth hormone stimulus (GO:0071378) | 2.77366337 |
| 57 | mannose metabolic process (GO:0006013) | 2.74685336 |
| 58 | lipid storage (GO:0019915) | 2.74351574 |
| 59 | cell wall macromolecule catabolic process (GO:0016998) | 2.74078184 |
| 60 | cell wall macromolecule metabolic process (GO:0044036) | 2.74078184 |
| 61 | biotin metabolic process (GO:0006768) | 2.73554594 |
| 62 | positive regulation of glycolytic process (GO:0045821) | 2.72892883 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 2.72276930 |
| 64 | positive regulation of p38MAPK cascade (GO:1900745) | 2.71981065 |
| 65 | regulation of memory T cell differentiation (GO:0043380) | 2.70278199 |
| 66 | sperm motility (GO:0030317) | 2.68786642 |
| 67 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.68473504 |
| 68 | regulation of early endosome to late endosome transport (GO:2000641) | 2.62782740 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 2.62192749 |
| 70 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62097736 |
| 71 | fatty acid oxidation (GO:0019395) | 2.61517195 |
| 72 | protein heterotrimerization (GO:0070208) | 2.58796937 |
| 73 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.57937214 |
| 74 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.57767520 |
| 75 | quaternary ammonium group transport (GO:0015697) | 2.56792901 |
| 76 | lipid oxidation (GO:0034440) | 2.54144417 |
| 77 | regulation of extracellular matrix organization (GO:1903053) | 2.53277254 |
| 78 | regulation of lipid storage (GO:0010883) | 2.52692389 |
| 79 | positive regulation of receptor recycling (GO:0001921) | 2.51923529 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 2.50837652 |
| 81 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.49699951 |
| 82 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.49529036 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.49289517 |
| 84 | hypotonic response (GO:0006971) | 2.48403724 |
| 85 | fatty acid catabolic process (GO:0009062) | 2.47853589 |
| 86 | endodermal cell differentiation (GO:0035987) | 2.46661453 |
| 87 | positive regulation of protein deacetylation (GO:0090312) | 2.46204240 |
| 88 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.44447095 |
| 89 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.44282519 |
| 90 | positive regulation of nuclease activity (GO:0032075) | 2.42829042 |
| 91 | triglyceride biosynthetic process (GO:0019432) | 2.42029879 |
| 92 | iron ion import (GO:0097286) | 2.42013325 |
| 93 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.40873519 |
| 94 | negative regulation of fibrinolysis (GO:0051918) | 2.40104211 |
| 95 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.39889159 |
| 96 | collagen fibril organization (GO:0030199) | 2.39849346 |
| 97 | regulation of lipid catabolic process (GO:0050994) | 2.39576605 |
| 98 | regulation of metalloenzyme activity (GO:0048552) | 2.39038934 |
| 99 | glucose catabolic process (GO:0006007) | 2.37444798 |
| 100 | regulation of p38MAPK cascade (GO:1900744) | 2.37183805 |
| 101 | negative regulation of granulocyte differentiation (GO:0030853) | 2.35657930 |
| 102 | chondrocyte proliferation (GO:0035988) | 2.34108729 |
| 103 | stress fiber assembly (GO:0043149) | 2.33958463 |
| 104 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.33449027 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 2.28852788 |
| 106 | neutral lipid biosynthetic process (GO:0046460) | 2.28779463 |
| 107 | acylglycerol biosynthetic process (GO:0046463) | 2.28779463 |
| 108 | negative regulation of Ras GTPase activity (GO:0034261) | 2.28708830 |
| 109 | blood vessel maturation (GO:0001955) | 2.28600232 |
| 110 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.28185538 |
| 111 | lipoprotein transport (GO:0042953) | 2.27421841 |
| 112 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.27155633 |
| 113 | carnitine metabolic process (GO:0009437) | 2.26824524 |
| 114 | cellular response to lithium ion (GO:0071285) | 2.26815561 |
| 115 | 4-hydroxyproline metabolic process (GO:0019471) | 2.26258602 |
| 116 | cell-substrate junction assembly (GO:0007044) | 2.26198655 |
| 117 | skin morphogenesis (GO:0043589) | 2.25458216 |
| 118 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.25333784 |
| 119 | negative regulation of innate immune response (GO:0045824) | 2.25174417 |
| 120 | venous blood vessel morphogenesis (GO:0048845) | 2.24183653 |
| 121 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.23588614 |
| 122 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.23086956 |
| 123 | cellular response to vitamin (GO:0071295) | 2.23082423 |
| 124 | basement membrane organization (GO:0071711) | 2.22775759 |
| 125 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.22569083 |
| 126 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.22496855 |
| 127 | phospholipid homeostasis (GO:0055091) | 2.22119063 |
| 128 | triglyceride metabolic process (GO:0006641) | 2.21837994 |
| 129 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.20852539 |
| 130 | endocardial cushion development (GO:0003197) | 2.19257650 |
| 131 | regulation of beta-amyloid formation (GO:1902003) | 2.19208257 |
| 132 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.15670516 |
| 133 | protein-lipid complex assembly (GO:0065005) | 2.14897882 |
| 134 | cell adhesion mediated by integrin (GO:0033627) | 2.14714708 |
| 135 | vesicle coating (GO:0006901) | 2.11764664 |
| 136 | fibril organization (GO:0097435) | 2.09065239 |
| 137 | focal adhesion assembly (GO:0048041) | 2.07461845 |
| 138 | cell-substrate adherens junction assembly (GO:0007045) | 2.07461845 |
| 139 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.04294330 |
| 140 | cortical actin cytoskeleton organization (GO:0030866) | 2.04094467 |
| 141 | positive regulation of fibroblast migration (GO:0010763) | 2.03421710 |
| 142 | regulation of ARF GTPase activity (GO:0032312) | 2.03130495 |
| 143 | extracellular fibril organization (GO:0043206) | 2.03106562 |
| 144 | regulation of apoptotic cell clearance (GO:2000425) | 2.02971362 |
| 145 | negative regulation of endocytosis (GO:0045806) | 2.01202234 |
| 146 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.00206573 |
| 147 | regulation of fibrinolysis (GO:0051917) | 1.99867297 |
| 148 | plasma lipoprotein particle assembly (GO:0034377) | 1.98900424 |
| 149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 1.98787540 |
| 150 | positive regulation of transforming growth factor beta production (GO:0071636) | 1.98321414 |
| 151 | sequestering of extracellular ligand from receptor (GO:0035581) | 1.98232042 |
| 152 | extracellular matrix assembly (GO:0085029) | 1.97768014 |
| 153 | regulation of transforming growth factor beta1 production (GO:0032908) | 1.97361556 |
| 154 | negative regulation of Ras protein signal transduction (GO:0046580) | 1.97261117 |
| 155 | retrograde transport, endosome to Golgi (GO:0042147) | 1.96668091 |
| 156 | import into cell (GO:0098657) | 1.95801491 |
| 157 | protein retention in ER lumen (GO:0006621) | 1.95534438 |
| 158 | stress granule assembly (GO:0034063) | 1.95419025 |
| 159 | eosinophil chemotaxis (GO:0048245) | 1.95004781 |
| 160 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.94918154 |
| 161 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 1.92155155 |
| 162 | barbed-end actin filament capping (GO:0051016) | 1.91745068 |
| 163 | regulation of ARF protein signal transduction (GO:0032012) | 1.91568602 |
| 164 | cellular response to nutrient (GO:0031670) | 1.91236037 |
| 165 | protein hydroxylation (GO:0018126) | 1.90565150 |
| 166 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 1.89652904 |
| 167 | regulation of integrin-mediated signaling pathway (GO:2001044) | 1.89409129 |
| 168 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.88656092 |
| 169 | chondroitin sulfate catabolic process (GO:0030207) | 1.88226898 |
| 170 | peptidyl-proline hydroxylation (GO:0019511) | 1.87444568 |
| 171 | regulation of plasminogen activation (GO:0010755) | 1.87126607 |
| 172 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.86805023 |
| 173 | endocytic recycling (GO:0032456) | 1.86304841 |
| 174 | protein targeting to plasma membrane (GO:0072661) | 1.86152627 |
| 175 | adhesion of symbiont to host (GO:0044406) | 1.85991537 |
| 176 | adherens junction assembly (GO:0034333) | 1.85090685 |
| 177 | chondroitin sulfate biosynthetic process (GO:0030206) | 1.84507999 |
| 178 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 1.84330112 |
| 179 | establishment of protein localization to vacuole (GO:0072666) | 1.83789790 |
| 180 | protein targeting to vacuole (GO:0006623) | 1.83789790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.23293020 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.16614296 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.02280431 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.02168604 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.53118224 |
| 6 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.51483660 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51449050 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38564975 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.29012811 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28495199 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23066298 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22212353 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11712902 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05660237 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03643200 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03543479 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.98110889 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95362997 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.95074856 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92464763 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87951614 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.83729076 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81964357 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81613001 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80985789 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80503604 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79202325 |
| 28 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.74989069 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73365096 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72561294 |
| 31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71560920 |
| 32 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.69529170 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63807948 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62186746 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59579102 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59460606 |
| 37 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59013731 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57572584 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.57007111 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56338322 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.56293278 |
| 42 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53199453 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51401805 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47718800 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47697828 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.47305785 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47109949 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45135418 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.44564573 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44395894 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43258955 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41544989 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41453624 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40163553 |
| 55 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.39223472 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38693608 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38267361 |
| 58 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38060384 |
| 59 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.36949899 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33725097 |
| 61 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32634180 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32150577 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31196407 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29298158 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28702300 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28652021 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28173005 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28173005 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27814903 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26239025 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.26041225 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25843020 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25421838 |
| 74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23445825 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23133807 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22864531 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22561635 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20601949 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18117623 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17770018 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17306829 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17044546 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16782031 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15744496 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15681171 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15515497 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15135712 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15093356 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14059930 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13356918 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12873782 |
| 92 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12529468 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11886834 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 1.11692309 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.11531540 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10801788 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10678655 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10303179 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09973789 |
| 100 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09963817 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09962739 |
| 102 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09071261 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09011718 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08506612 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08122611 |
| 106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08018920 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07811896 |
| 108 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05376908 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04998910 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.02215283 |
| 111 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00442318 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99871356 |
| 113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99776931 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98984152 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98782588 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97969842 |
| 117 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97506296 |
| 118 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96068116 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96066968 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95783703 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95558706 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95469411 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95122229 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94994257 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94943269 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94667587 |
| 127 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93714437 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93672302 |
| 129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.93272577 |
| 130 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92686205 |
| 131 | P68_20966046_ChIP-Seq_HELA_Human | 0.92352813 |
| 132 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92295429 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92276032 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92014342 |
| 135 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91806239 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91378657 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91340986 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90522524 |
| 139 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90412564 |
| 140 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90412564 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90235416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 3.83584951 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.31318501 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.29589698 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 2.73419190 |
| 5 | MP0005666_abnormal_adipose_tissue | 2.71287872 |
| 6 | MP0004130_abnormal_muscle_cell | 2.61486105 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.47799673 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.37696391 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.25509841 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.15916402 |
| 11 | MP0005409_darkened_coat_color | 2.15168511 |
| 12 | MP0005410_abnormal_fertilization | 2.09800650 |
| 13 | MP0005275_abnormal_skin_tensile | 2.07377468 |
| 14 | MP0005375_adipose_tissue_phenotype | 2.05753085 |
| 15 | MP0003303_peritoneal_inflammation | 1.97164555 |
| 16 | MP0003566_abnormal_cell_adhesion | 1.87448777 |
| 17 | MP0009840_abnormal_foam_cell | 1.87049077 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.80341815 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 1.77974979 |
| 20 | MP0003329_amyloid_beta_deposits | 1.73235443 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.72141435 |
| 22 | MP0003436_decreased_susceptibility_to | 1.70497460 |
| 23 | MP0000566_synostosis | 1.63715796 |
| 24 | MP0009384_cardiac_valve_regurgitation | 1.63383915 |
| 25 | MP0005451_abnormal_body_composition | 1.61223001 |
| 26 | MP0002971_abnormal_brown_adipose | 1.60870945 |
| 27 | MP0008260_abnormal_autophagy | 1.56196083 |
| 28 | MP0000371_diluted_coat_color | 1.48562203 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.47840061 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.47497357 |
| 31 | MP0009278_abnormal_bone_marrow | 1.46029132 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.44460566 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.44071089 |
| 34 | MP0009115_abnormal_fat_cell | 1.42272184 |
| 35 | MP0005365_abnormal_bile_salt | 1.41799490 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.41203416 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.40415981 |
| 38 | MP0001958_emphysema | 1.40344311 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.39099067 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.36925589 |
| 41 | MP0000767_abnormal_smooth_muscle | 1.36547087 |
| 42 | MP0004233_abnormal_muscle_weight | 1.33202514 |
| 43 | MP0000609_abnormal_liver_physiology | 1.31657053 |
| 44 | MP0005360_urolithiasis | 1.29756654 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.28797493 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.28556354 |
| 47 | MP0002896_abnormal_bone_mineralization | 1.27404525 |
| 48 | MP0006054_spinal_hemorrhage | 1.26312558 |
| 49 | MP0004947_skin_inflammation | 1.24530073 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.23976261 |
| 51 | MP0004510_myositis | 1.23354121 |
| 52 | MP0008004_abnormal_stomach_pH | 1.22226052 |
| 53 | MP0003279_aneurysm | 1.21923708 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.21492263 |
| 55 | MP0003045_fibrosis | 1.21382675 |
| 56 | MP0000343_altered_response_to | 1.21337807 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.19889173 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.19889173 |
| 59 | MP0000685_abnormal_immune_system | 1.19695259 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.18803768 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.17593008 |
| 62 | MP0005508_abnormal_skeleton_morphology | 1.16281385 |
| 63 | MP0001915_intracranial_hemorrhage | 1.15827511 |
| 64 | MP0005023_abnormal_wound_healing | 1.15361795 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.13272703 |
| 66 | MP0005334_abnormal_fat_pad | 1.12552850 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 1.11034000 |
| 68 | MP0002419_abnormal_innate_immunity | 1.10950619 |
| 69 | MP0002933_joint_inflammation | 1.09578622 |
| 70 | MP0003448_altered_tumor_morphology | 1.09531290 |
| 71 | MP0002006_tumorigenesis | 1.06972589 |
| 72 | MP0002060_abnormal_skin_morphology | 1.06706447 |
| 73 | MP0000534_abnormal_ureter_morphology | 1.04572066 |
| 74 | MP0003091_abnormal_cell_migration | 1.04220099 |
| 75 | MP0010307_abnormal_tumor_latency | 1.03216858 |
| 76 | MP0002970_abnormal_white_adipose | 1.00857813 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.00702349 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.00550221 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.00414846 |
| 80 | MP0005164_abnormal_response_to | 1.00054467 |
| 81 | MP0001666_abnormal_nutrient_absorption | 0.99880869 |
| 82 | MP0005390_skeleton_phenotype | 0.99816500 |
| 83 | MP0000858_altered_metastatic_potential | 0.98714815 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.98572046 |
| 85 | MP0004858_abnormal_nervous_system | 0.96911893 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.96872226 |
| 87 | MP0003724_increased_susceptibility_to | 0.96458306 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.95328483 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.93810060 |
| 90 | MP0005000_abnormal_immune_tolerance | 0.93314671 |
| 91 | MP0002452_abnormal_antigen_presenting | 0.92184857 |
| 92 | MP0001790_abnormal_immune_system | 0.91953577 |
| 93 | MP0005387_immune_system_phenotype | 0.91953577 |
| 94 | MP0005083_abnormal_biliary_tract | 0.90580037 |
| 95 | MP0001881_abnormal_mammary_gland | 0.88931263 |
| 96 | MP0000733_abnormal_muscle_development | 0.88056321 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.87740879 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.87686465 |
| 99 | MP0000604_amyloidosis | 0.87346742 |
| 100 | MP0001270_distended_abdomen | 0.87329355 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.86972333 |
| 102 | MP0003075_altered_response_to | 0.86647588 |
| 103 | MP0003646_muscle_fatigue | 0.86593896 |
| 104 | MP0005025_abnormal_response_to | 0.85908594 |
| 105 | MP0009785_altered_susceptibility_to | 0.85877130 |
| 106 | MP0001542_abnormal_bone_strength | 0.84452987 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.83974988 |
| 108 | MP0004272_abnormal_basement_membrane | 0.83710373 |
| 109 | MP0001661_extended_life_span | 0.83523935 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.83456688 |
| 111 | MP0003115_abnormal_respiratory_system | 0.83452714 |
| 112 | MP0001756_abnormal_urination | 0.82838172 |
| 113 | MP0005171_absent_coat_pigmentation | 0.81904675 |
| 114 | MP0000598_abnormal_liver_morphology | 0.81771156 |
| 115 | MP0008469_abnormal_protein_level | 0.81639960 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.81119359 |
| 117 | MP0010630_abnormal_cardiac_muscle | 0.80638750 |
| 118 | MP0001800_abnormal_humoral_immune | 0.80560396 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.79159107 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79088440 |
| 121 | MP0001849_ear_inflammation | 0.78900849 |
| 122 | MP0003252_abnormal_bile_duct | 0.75817145 |
| 123 | MP0000428_abnormal_craniofacial_morphol | 0.75776873 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.75392022 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.75348589 |
| 126 | MP0001819_abnormal_immune_cell | 0.75215543 |
| 127 | MP0002723_abnormal_immune_serum | 0.74745745 |
| 128 | MP0006082_CNS_inflammation | 0.74447801 |
| 129 | MP0002108_abnormal_muscle_morphology | 0.73419111 |
| 130 | MP0003690_abnormal_glial_cell | 0.73236386 |
| 131 | MP0002168_other_aberrant_phenotype | 0.73136607 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.72360500 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.72198261 |
| 134 | MP0005408_hypopigmentation | 0.71733793 |
| 135 | MP0002075_abnormal_coat/hair_pigmentati | 0.71510844 |
| 136 | MP0003942_abnormal_urinary_system | 0.70922602 |
| 137 | MP0000249_abnormal_blood_vessel | 0.70837684 |
| 138 | MP0004381_abnormal_hair_follicle | 0.70406895 |
| 139 | MP0003879_abnormal_hair_cell | 0.69040682 |
| 140 | MP0001175_abnormal_lung_morphology | 0.68552123 |
| 141 | MP0002113_abnormal_skeleton_development | 0.67665835 |
| 142 | MP0002128_abnormal_blood_circulation | 0.67663145 |
| 143 | MP0001664_abnormal_digestion | 0.67366653 |
| 144 | MP0000920_abnormal_myelination | 0.66618944 |
| 145 | MP0003183_abnormal_peptide_metabolism | 0.65826050 |
| 146 | MP0003868_abnormal_feces_composition | 0.63063033 |
| 147 | MP0005174_abnormal_tail_pigmentation | 0.61713763 |
| 148 | MP0001614_abnormal_blood_vessel | 0.61171149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vascular tortuosity (HP:0004948) | 3.62525030 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.57519856 |
| 3 | Arterial tortuosity (HP:0005116) | 3.45131920 |
| 4 | Nasal polyposis (HP:0100582) | 3.39206501 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.29034906 |
| 6 | Abnormality of the nasal mucosa (HP:0000433) | 3.27279265 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.00820359 |
| 8 | Premature rupture of membranes (HP:0001788) | 2.93219066 |
| 9 | Mitral stenosis (HP:0001718) | 2.91956685 |
| 10 | Myocardial infarction (HP:0001658) | 2.91829496 |
| 11 | Soft skin (HP:0000977) | 2.88434011 |
| 12 | Ankle contracture (HP:0006466) | 2.80684164 |
| 13 | Bladder diverticulum (HP:0000015) | 2.75733926 |
| 14 | Aortic aneurysm (HP:0004942) | 2.72231301 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 2.70279410 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 2.70267055 |
| 17 | Hematochezia (HP:0002573) | 2.64468622 |
| 18 | Increased connective tissue (HP:0009025) | 2.62494860 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.58989074 |
| 20 | Wormian bones (HP:0002645) | 2.58800072 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.55984609 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 2.55984609 |
| 23 | Myoglobinuria (HP:0002913) | 2.51809540 |
| 24 | Aortic dissection (HP:0002647) | 2.49711291 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 2.46875587 |
| 26 | Ovoid vertebral bodies (HP:0003300) | 2.45450630 |
| 27 | Oligomenorrhea (HP:0000876) | 2.43509847 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.41844425 |
| 29 | Mucopolysacchariduria (HP:0008155) | 2.41844425 |
| 30 | Follicular hyperkeratosis (HP:0007502) | 2.38790322 |
| 31 | Blue sclerae (HP:0000592) | 2.38766685 |
| 32 | Abnormality of proline metabolism (HP:0010907) | 2.36637259 |
| 33 | Hydroxyprolinuria (HP:0003080) | 2.36637259 |
| 34 | Aneurysm (HP:0002617) | 2.35507852 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.35062329 |
| 36 | Spondylolisthesis (HP:0003302) | 2.34507846 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.34471802 |
| 38 | Flared iliac wings (HP:0002869) | 2.33440377 |
| 39 | Dilatation of the ascending aorta (HP:0005111) | 2.32865900 |
| 40 | Xanthomatosis (HP:0000991) | 2.32621393 |
| 41 | Cervical subluxation (HP:0003308) | 2.32578684 |
| 42 | Gingival bleeding (HP:0000225) | 2.32294105 |
| 43 | Atrophic scars (HP:0001075) | 2.32037431 |
| 44 | Neonatal short-limb short stature (HP:0008921) | 2.31685353 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.31360998 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.29709287 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.29709287 |
| 48 | Fragile skin (HP:0001030) | 2.29594557 |
| 49 | Mitral valve prolapse (HP:0001634) | 2.28982909 |
| 50 | Hypertriglyceridemia (HP:0002155) | 2.26541545 |
| 51 | Peritonitis (HP:0002586) | 2.25812941 |
| 52 | Hyperglycinuria (HP:0003108) | 2.25176461 |
| 53 | Broad metatarsal (HP:0001783) | 2.24663435 |
| 54 | Action tremor (HP:0002345) | 2.24561468 |
| 55 | Acanthosis nigricans (HP:0000956) | 2.21100631 |
| 56 | Long toe (HP:0010511) | 2.20427186 |
| 57 | Tetraparesis (HP:0002273) | 2.20316896 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.19999836 |
| 59 | Complement deficiency (HP:0004431) | 2.19791755 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17783630 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17783630 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17783630 |
| 63 | Polycythemia (HP:0001901) | 2.17223542 |
| 64 | Obstructive sleep apnea (HP:0002870) | 2.17056843 |
| 65 | Dysmetric saccades (HP:0000641) | 2.17026179 |
| 66 | Flat acetabular roof (HP:0003180) | 2.15714897 |
| 67 | Hyperextensible skin (HP:0000974) | 2.14089077 |
| 68 | Venous insufficiency (HP:0005293) | 2.11385928 |
| 69 | Purpura (HP:0000979) | 2.10640730 |
| 70 | Abnormality of the acetabulum (HP:0003170) | 2.09727853 |
| 71 | Mitral regurgitation (HP:0001653) | 2.08092978 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.07665018 |
| 73 | Shallow orbits (HP:0000586) | 2.07176356 |
| 74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05978899 |
| 75 | Thin bony cortex (HP:0002753) | 2.04911788 |
| 76 | Bone cyst (HP:0012062) | 2.03939295 |
| 77 | Enlarged penis (HP:0000040) | 2.02672943 |
| 78 | Spinal rigidity (HP:0003306) | 2.02614758 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.01808591 |
| 80 | Difficulty running (HP:0009046) | 2.01641570 |
| 81 | Hypoglycemic coma (HP:0001325) | 2.01633482 |
| 82 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.00570868 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.00171832 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98071295 |
| 85 | Venous abnormality (HP:0002624) | 1.97953242 |
| 86 | Hypoalphalipoproteinemia (HP:0003233) | 1.97377485 |
| 87 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.96810606 |
| 88 | Joint laxity (HP:0001388) | 1.96722111 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.96302453 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94509610 |
| 91 | Difficulty climbing stairs (HP:0003551) | 1.94250652 |
| 92 | Loss of speech (HP:0002371) | 1.94225765 |
| 93 | Skin nodule (HP:0200036) | 1.93824440 |
| 94 | Menorrhagia (HP:0000132) | 1.92158672 |
| 95 | Right ventricular cardiomyopathy (HP:0011663) | 1.91768460 |
| 96 | Abnormal cartilage morphology (HP:0002763) | 1.91533028 |
| 97 | Ulnar bowing (HP:0003031) | 1.90199013 |
| 98 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89979571 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89979571 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89979571 |
| 101 | Recurrent abscess formation (HP:0002722) | 1.89052533 |
| 102 | Abnormality of complement system (HP:0005339) | 1.88292625 |
| 103 | Global brain atrophy (HP:0002283) | 1.87967449 |
| 104 | Male infertility (HP:0003251) | 1.87891388 |
| 105 | Disproportionate tall stature (HP:0001519) | 1.86987440 |
| 106 | Cellulitis (HP:0100658) | 1.86985505 |
| 107 | Recurrent bacterial skin infections (HP:0005406) | 1.86902080 |
| 108 | Aortic regurgitation (HP:0001659) | 1.86660688 |
| 109 | Facial diplegia (HP:0001349) | 1.86034221 |
| 110 | Hyporeflexia of lower limbs (HP:0002600) | 1.85771670 |
| 111 | Hypercholesterolemia (HP:0003124) | 1.84861367 |
| 112 | Axonal loss (HP:0003447) | 1.83536012 |
| 113 | Colitis (HP:0002583) | 1.83506945 |
| 114 | Slow saccadic eye movements (HP:0000514) | 1.83353286 |
| 115 | Lymphangioma (HP:0100764) | 1.83025453 |
| 116 | Bruising susceptibility (HP:0000978) | 1.80936369 |
| 117 | Dislocated radial head (HP:0003083) | 1.80530316 |
| 118 | Overgrowth (HP:0001548) | 1.79405137 |
| 119 | Genu recurvatum (HP:0002816) | 1.79076582 |
| 120 | Polygenic inheritance (HP:0010982) | 1.78314557 |
| 121 | Systemic lupus erythematosus (HP:0002725) | 1.77945219 |
| 122 | Multiple enchondromatosis (HP:0005701) | 1.77495371 |
| 123 | Joint stiffness (HP:0001387) | 1.77072145 |
| 124 | Striae distensae (HP:0001065) | 1.75654927 |
| 125 | Ketosis (HP:0001946) | 1.75486049 |
| 126 | Gastrointestinal infarctions (HP:0005244) | 1.75448565 |
| 127 | Slender build (HP:0001533) | 1.74542562 |
| 128 | Vacuolated lymphocytes (HP:0001922) | 1.73359343 |
| 129 | Fatigue (HP:0012378) | 1.73339779 |
| 130 | Periodontitis (HP:0000704) | 1.72809405 |
| 131 | Conjunctival hamartoma (HP:0100780) | 1.72698597 |
| 132 | Osteoarthritis (HP:0002758) | 1.72211250 |
| 133 | Insulin resistance (HP:0000855) | 1.72062913 |
| 134 | Protuberant abdomen (HP:0001538) | 1.71568489 |
| 135 | Deep venous thrombosis (HP:0002625) | 1.71274032 |
| 136 | Spontaneous hematomas (HP:0007420) | 1.71052388 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70759223 |
| 138 | Chronic otitis media (HP:0000389) | 1.70421976 |
| 139 | Coxa vara (HP:0002812) | 1.70164523 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69730903 |
| 141 | Abnormality of purine metabolism (HP:0004352) | 1.69631460 |
| 142 | Genetic anticipation (HP:0003743) | 1.69600709 |
| 143 | Asymmetry of the thorax (HP:0001555) | 1.69597236 |
| 144 | Prolonged bleeding time (HP:0003010) | 1.69521067 |
| 145 | Abnormality of carpal bone ossification (HP:0006257) | 1.69386921 |
| 146 | Increased IgE level (HP:0003212) | 1.69269353 |
| 147 | Ulnar deviation of the wrist (HP:0003049) | 1.68949033 |
| 148 | Rectal prolapse (HP:0002035) | 1.68859754 |
| 149 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67608724 |
| 150 | Cerebral inclusion bodies (HP:0100314) | 1.67441121 |
| 151 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.67365392 |
| 152 | Disinhibition (HP:0000734) | 1.67143125 |
| 153 | Joint hemorrhage (HP:0005261) | 1.66790231 |
| 154 | Aortic valve stenosis (HP:0001650) | 1.66730408 |
| 155 | Atelectasis (HP:0100750) | 1.66421862 |
| 156 | Coarse hair (HP:0002208) | 1.64665573 |
| 157 | Hypercortisolism (HP:0001578) | 1.63471544 |
| 158 | Hypoplasia of the odontoid process (HP:0003311) | 1.63162241 |
| 159 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.62931981 |
| 160 | Cupped ribs (HP:0000887) | 1.61739766 |
| 161 | Abnormality of the radial head (HP:0003995) | 1.61410285 |
| 162 | Biconcave vertebral bodies (HP:0004586) | 1.61344060 |
| 163 | Epistaxis (HP:0000421) | 1.60700299 |
| 164 | Abnormality of dentin (HP:0010299) | 1.59720197 |
| 165 | Abnormality of the common coagulation pathway (HP:0010990) | 1.55806231 |
| 166 | Postural tremor (HP:0002174) | 1.55644114 |
| 167 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.54231280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.31693965 |
| 2 | PKN2 | 3.57843563 |
| 3 | ERN1 | 3.53463179 |
| 4 | TAOK2 | 2.80030624 |
| 5 | PDK3 | 2.58310287 |
| 6 | PDK4 | 2.58310287 |
| 7 | EEF2K | 2.36491005 |
| 8 | CAMK1D | 2.29778197 |
| 9 | MST1R | 2.26435849 |
| 10 | MKNK2 | 2.19970420 |
| 11 | PRPF4B | 2.18586591 |
| 12 | MAP3K11 | 2.04844876 |
| 13 | RIPK1 | 2.01150345 |
| 14 | SIK1 | 1.97572853 |
| 15 | MAP3K10 | 1.85281131 |
| 16 | PRKD3 | 1.83393808 |
| 17 | TTN | 1.80732372 |
| 18 | TESK1 | 1.80127918 |
| 19 | CAMK1G | 1.72695668 |
| 20 | EPHB1 | 1.66178546 |
| 21 | FGFR4 | 1.63666203 |
| 22 | PTK6 | 1.59917606 |
| 23 | PDK2 | 1.56083533 |
| 24 | ICK | 1.56042619 |
| 25 | PRKD2 | 1.53605764 |
| 26 | KSR2 | 1.49509642 |
| 27 | TGFBR2 | 1.49497114 |
| 28 | PDGFRA | 1.46032476 |
| 29 | LRRK2 | 1.44815594 |
| 30 | EPHA3 | 1.42246851 |
| 31 | CDC42BPA | 1.40777778 |
| 32 | MAP4K1 | 1.37319010 |
| 33 | WNK1 | 1.35275328 |
| 34 | BCKDK | 1.29429204 |
| 35 | MAP3K2 | 1.27663355 |
| 36 | TBK1 | 1.24734469 |
| 37 | MARK2 | 1.23492929 |
| 38 | FGFR3 | 1.22823754 |
| 39 | FLT3 | 1.19807523 |
| 40 | JAK1 | 1.19596933 |
| 41 | AKT3 | 1.16076962 |
| 42 | SCYL2 | 1.15621152 |
| 43 | TRPM7 | 1.13273013 |
| 44 | FRK | 1.12148255 |
| 45 | HIPK2 | 1.10585454 |
| 46 | NTRK1 | 1.09462928 |
| 47 | TYK2 | 1.08525226 |
| 48 | ZAP70 | 1.07608250 |
| 49 | ABL2 | 1.04050444 |
| 50 | RET | 1.02932516 |
| 51 | LATS1 | 1.02430148 |
| 52 | NEK9 | 1.02373458 |
| 53 | STK3 | 1.02069370 |
| 54 | BMX | 0.99416753 |
| 55 | JAK3 | 0.98237797 |
| 56 | PDK1 | 0.94926753 |
| 57 | TYRO3 | 0.94679249 |
| 58 | MAP2K3 | 0.93359207 |
| 59 | PDPK1 | 0.90686462 |
| 60 | RIPK4 | 0.90443627 |
| 61 | MYLK | 0.90043875 |
| 62 | JAK2 | 0.89483900 |
| 63 | TAOK1 | 0.88957200 |
| 64 | RPS6KA4 | 0.87557461 |
| 65 | MAP3K3 | 0.84159820 |
| 66 | LATS2 | 0.83275002 |
| 67 | PAK4 | 0.82679249 |
| 68 | SMG1 | 0.82580687 |
| 69 | WNK4 | 0.82562061 |
| 70 | MET | 0.80885217 |
| 71 | MTOR | 0.79581134 |
| 72 | IRAK3 | 0.77862948 |
| 73 | MAP3K13 | 0.77854644 |
| 74 | PTK2B | 0.76607190 |
| 75 | PDGFRB | 0.76604720 |
| 76 | CAMKK1 | 0.76440907 |
| 77 | CDK6 | 0.76007569 |
| 78 | MAP3K5 | 0.75261166 |
| 79 | RPS6KA2 | 0.74592305 |
| 80 | DDR2 | 0.74341458 |
| 81 | MAP3K6 | 0.73600607 |
| 82 | MAP2K1 | 0.71351932 |
| 83 | STK10 | 0.71041263 |
| 84 | DMPK | 0.70940514 |
| 85 | SGK3 | 0.70016202 |
| 86 | KIT | 0.69585658 |
| 87 | MAP3K1 | 0.68352073 |
| 88 | MAPK7 | 0.66986535 |
| 89 | DYRK1B | 0.66686217 |
| 90 | PAK2 | 0.66436258 |
| 91 | MAP2K2 | 0.65018638 |
| 92 | CDK12 | 0.64998934 |
| 93 | MELK | 0.64761934 |
| 94 | PRKAA2 | 0.63952735 |
| 95 | STK38 | 0.63711289 |
| 96 | FGFR2 | 0.62441083 |
| 97 | MAPKAPK3 | 0.60231818 |
| 98 | PTK2 | 0.59836910 |
| 99 | CSK | 0.58769207 |
| 100 | TAOK3 | 0.57572120 |
| 101 | MAPK12 | 0.56810568 |
| 102 | CDK4 | 0.56350615 |
| 103 | LMTK2 | 0.56341165 |
| 104 | HCK | 0.56291399 |
| 105 | CSF1R | 0.55925120 |
| 106 | PRKCH | 0.54839359 |
| 107 | SIK2 | 0.54267481 |
| 108 | DAPK2 | 0.53441450 |
| 109 | ILK | 0.53151858 |
| 110 | IRAK1 | 0.52729907 |
| 111 | NEK2 | 0.51545260 |
| 112 | PIM1 | 0.51378713 |
| 113 | PIK3CA | 0.50170540 |
| 114 | BLK | 0.50159239 |
| 115 | DYRK1A | 0.49971668 |
| 116 | CDK9 | 0.48973003 |
| 117 | ALK | 0.47591350 |
| 118 | TNK2 | 0.47507524 |
| 119 | BTK | 0.46990777 |
| 120 | NTRK3 | 0.46876104 |
| 121 | GRK6 | 0.45501714 |
| 122 | IKBKE | 0.43162679 |
| 123 | MAP3K7 | 0.42947212 |
| 124 | YES1 | 0.42932812 |
| 125 | PRKG2 | 0.42612530 |
| 126 | MAPK11 | 0.41549035 |
| 127 | MAP3K8 | 0.40746915 |
| 128 | KDR | 0.40710994 |
| 129 | CDK19 | 0.38856591 |
| 130 | RPS6KC1 | 0.38412452 |
| 131 | RPS6KL1 | 0.38412452 |
| 132 | EPHA2 | 0.37293269 |
| 133 | FGR | 0.37185121 |
| 134 | CHUK | 0.36431268 |
| 135 | PRKD1 | 0.35644068 |
| 136 | MKNK1 | 0.35543404 |
| 137 | PRKAA1 | 0.34916873 |
| 138 | MAP3K14 | 0.34544847 |
| 139 | PAK6 | 0.34343837 |
| 140 | ITK | 0.32139107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.63807726 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.56516433 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30191683 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20468703 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18452133 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06292911 |
| 7 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.84366570 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.75059384 |
| 9 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.73966813 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64698966 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.60719059 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.59609412 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 1.58138058 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57674037 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57156002 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57026457 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47532925 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.39874986 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38368249 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37217754 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35368799 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31313279 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26512129 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25988769 |
| 25 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.25192470 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19950359 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16593931 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16560997 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14838059 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14807447 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14720642 |
| 32 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13450558 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11995112 |
| 34 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09992845 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09638138 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09357105 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09108644 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08805433 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05897719 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04558941 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02366526 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01991342 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00914778 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00884675 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00467519 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98808618 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 0.95553977 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.95001554 |
| 49 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94720592 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93327182 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93319870 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.92668955 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91720077 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90909186 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90392182 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.90382750 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90090117 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89756258 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.89459822 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89447097 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88804177 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.88616754 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.87599395 |
| 64 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86023629 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85197696 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84616204 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84490948 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84218243 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84011926 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.83758871 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83262527 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83071424 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82592531 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81678978 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81518595 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80458899 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.80206258 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80025444 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79563364 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78635224 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77804397 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76908118 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75860578 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75254707 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.73878571 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73550094 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.73501935 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73419908 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73139928 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72087008 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71544023 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71492936 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71267918 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71017305 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70640782 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70560571 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70069848 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69067479 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67974674 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.67166170 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66913851 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66456393 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66395010 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66392565 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.66300663 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.65250185 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.65175614 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64845519 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64659078 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64656818 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64380607 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63686994 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63492586 |
| 114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63491045 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63394544 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63183761 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.62407873 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.61548915 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61083072 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60861740 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.59023103 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58748415 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58176751 |
| 124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57850615 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57731740 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57436759 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57203314 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56967223 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55951807 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55698929 |
| 131 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55514398 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.55378250 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.55333672 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.55175985 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.54534445 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.54097877 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53954879 |
| 138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52891428 |
| 139 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52649954 |
| 140 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52623515 |
| 141 | Peroxisome_Homo sapiens_hsa04146 | 0.52250611 |
| 142 | Measles_Homo sapiens_hsa05162 | 0.51656256 |
| 143 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50005099 |
| 144 | Glioma_Homo sapiens_hsa05214 | 0.49931958 |

